Investor Relations

Sep 12, 2017 at 11:40 AM ET
Galectin Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference


Corporate Profile

Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function... (more)